Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

diffuse alveolar hemorrhage News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

Recent case reports highlight life-threatening diffuse alveolar hemorrhage linked to rhinovirus infection in immunocompetent patients. The findings suggest a potential role for corticosteroids in treatment, warranting further investigation.

A case report details two instances of diffuse alveolar hemorrhage linked to human metapneumovirus infection. This research highlights the potential severe respiratory complications associated with this viral infection.

A recent study published in PubMed examines the clinical, radiological, and laboratory features of diffuse alveolar hemorrhage, providing insights into patient outcomes. This research contributes to the understanding of this rare condition and may inform future clinical practices.

A review highlights the use of CD20 monoclonal antibody rituximab for treating diffuse alveolar hemorrhage in children. This study provides insights into the potential therapeutic applications of rituximab in this rare condition.

Not rare diseases news,news about your rare disease.

Earlier

Recent case reports highlight life-threatening diffuse alveolar hemorrhage linked to rhinovirus infection in immunocompetent patients. The findings suggest a potential role for corticosteroids in treatment, warranting further investigation.

A case report details two instances of diffuse alveolar hemorrhage linked to human metapneumovirus infection. This research highlights the potential severe respiratory complications associated with this viral infection.

A recent study published in PubMed examines the clinical, radiological, and laboratory features of diffuse alveolar hemorrhage, providing insights into patient outcomes. This research contributes to the understanding of this rare condition and may inform future clinical practices.

A review highlights the use of CD20 monoclonal antibody rituximab for treating diffuse alveolar hemorrhage in children. This study provides insights into the potential therapeutic applications of rituximab in this rare condition.

Not rare diseases news,
news about your rare disease.